Results

Total Results: 1,565 records

Showing results for "occurring".

341. Metabolic Disorders | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/metabolic-disorders
     July 28, 2017 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

342. Metabolic Disorders | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/metabolic-disorders?page=1
     June 05, 2013 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

343. Metabolic Disorders | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/metabolic-disorders?page=2
     January 17, 2012 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

344. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - Layout 1 Background Anemia (deficiency of red blood cells) occurs in 13-78 percent of patients undergoing treatment for solid tumors and 30-40 percent of patients treated for lymphoma. Tumor type, treatment regimen, and history of prior cancer therapy influence the risk and severity of anemia. For example, among pa…

345. Gout Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - NSAIDs also have gastrointestinal side effects, with dyspepsia or abdominal pain occurring in 10 percent … or more of patients and more serious GI perforations, ulcers, and bleeds occurring in fewer than one … • The most common adverse event associated with allopurinol is a skin rash, occurring in up to 5 percent

346. App-D-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
     September 30, 2015 - ability to pay; approval from PCP Exclusion: member of vulnerable population (including prisoners); co-occurring

347. Procalcitonin for Diagnosis and Management of Sepsis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/procalcitonin/research-protocol
     December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

348. Models of Care That Include Primary Care for Adult Survivors of Childhood Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/pediatric-adolescent-cancer-survivorship/protocol
     December 01, 2020 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

349. Comparative Effectiveness of Treatment for Phenylketonuria | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/phenylketonuria/research-protocol
     December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

350. Cerebral-Palsy-Feeding Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_executive.pdf
     March 01, 2013 - disorder.”1 This group of syndromes ranges in severity and is the result of a variety of etiologies occurring … manifestations may change over time as the brain develops, with other neurologic impairments frequently co-occurring

351. Abnormal-Uterine-Bleeding Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/abnormal-uterine-bleeding_research-protocol.pdf
     November 21, 2011 - intervals) and amount (heavy or light) to infer whether or not regular and predictable ovulation was occurring … studies, post-surveillance data studies, and registries/databases of sufficient size to detect harms occurring

352. Antipsychotics-Children Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
     June 04, 2010 - Short-term is defined as outcomes occurring within 6 months; long-term is defined as outcomes occurring

353. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
     February 16, 2011 - Objectives for the Systematic Review Background Chronic pelvic pain (CPP) in women is a commonly occurring … The prevalence of noncyclic pelvic pain (i.e., not occurring in concert with menstruation or in a temporal

354. PKU Surveillance Assessment_CER 56_Low (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
     January 15, 2013 - Genotypes occurring in 2 or more patients were consistently associated with results of the START … Genotypes occurring in 2 or more patients were consistently associated with results of the START test

355. S58 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s58.pdf
     October 01, 2007 - smaller-scale studies, indices such as the Charlson Comorbidity Index are often used to control for co-occurring … be an important consideration and it may be appropriate to adjust separately for each relevant co- occurring

356. Disposition of comments_Comparative Effectiveness Review No. 244: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-244-safety-of-vaccines.pdf
     May 25, 2021 - pdf file on “Another was material seizures, with an RR of 2.07 (CI 0.12, 32.41), due to seizures occurring

357. Primary Care Management of Abnormal Uterine Bleeding (AUB) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/abnormal-uterine-bleeding/research-protocol
     December 01, 2020 - intervals) and amount (heavy or light) to infer whether or not regular and predictable ovulation was occurring … studies, post-surveillance data studies, and registries/databases of sufficient size to detect harms occurring

358. Single-arm studies in comparative effectiveness reviews (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
     January 01, 2013 - Single-arm studies in comparative effectiveness reviews Research White Paper Role of Single Group Studies in Agency for Healthcare Research and Quality Comparative Effectiveness Reviews …

359. Plasma-Cell-Dyscrasias-Sflc-Assay Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
     August 01, 2012 - 1 Comparative Effectiveness Review Number 73 Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias Executive Summary Background Plasma cell dyscrasias (PCDs) are a group of neoplastic disorders characterized by the uninhibited expansion of a monoclonal popula…

360. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
     September 01, 2014 - Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Combination Therapy Versus Intensification of Statin Monotherapy: An Update. Draft revi…